Cristiane Ritter Selected Research

Cristiane Ritter Research Topics

Disease

36	Sepsis (Septicemia) 01/2023 - 02/2003
15	Critical Illness (Critically Ill) 12/2023 - 01/2011
14	Delirium 12/2023 - 01/2011
11	Inflammation (Inflammations) 01/2023 - 11/2004
7	Acute Kidney Injury (Acute Renal Failure) 03/2020 - 07/2009
6	Cognitive Dysfunction 04/2023 - 01/2005
5	Confusion (Bewilderment) 04/2015 - 01/2011
4	Coma (Comas) 12/2023 - 12/2012
4	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 02/2004
3	Pneumonia (Pneumonitis) 04/2021 - 11/2004
3	Hypotension (Low Blood Pressure) 03/2020 - 09/2012
3	Septic Shock (Toxic Shock Syndrome) 10/2012 - 02/2004
2	COVID-19 07/2023 - 01/2022
2	Encephalitis (Encephalitis, Rasmussen) 01/2021 - 02/2014
2	Sepsis-Associated Encephalopathy 01/2021 - 05/2013
2	Hypoxia (Hypoxemia) 02/2018 - 06/2008
2	Ischemia 02/2018 - 09/2012
2	Lung Injury 02/2010 - 02/2006
2	Acute Lung Injury 02/2006 - 01/2006
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2023
1	Dysbiosis 09/2022
1	Intestinal Diseases (Diseases, Intestinal) 09/2022
1	Necrotizing Enterocolitis 09/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Smoke Inhalation Injury 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Hyperammonemia 01/2020
1	Hepatic Encephalopathy 01/2020
1	Glioma (Gliomas) 01/2019
1	Autoimmune Diseases of the Nervous System 01/2019
1	Chronic Limb-Threatening Ischemia 02/2018

Drug/Important Bio-Agent (IBA)

13	AntioxidantsIBA 03/2020 - 08/2003
10	Biomarkers (Surrogate Marker)IBA 07/2023 - 12/2010
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
9	Acetylcysteine (Siran)FDA LinkGeneric 03/2020 - 02/2004
8	CytokinesIBA 01/2023 - 01/2006
8	Deferoxamine (Desferal)FDA LinkGeneric 03/2020 - 02/2004
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 05/2005
5	Interleukin-6 (Interleukin 6)IBA 04/2023 - 07/2009
5	Thiobarbituric Acid Reactive SubstancesIBA 02/2018 - 08/2007
5	Superoxides (Superoxide)IBA 12/2017 - 02/2003
5	salicylhydroxamic acid (SHAM)IBA 01/2017 - 10/2003
4	Interleukin-10 (Interleukin 10)IBA 04/2023 - 07/2009
4	Superoxide DismutaseIBA 12/2017 - 08/2003
3	Matrix Metalloproteinases (MMPs)IBA 01/2023 - 06/2011
3	InterleukinsIBA 01/2017 - 07/2009
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 04/2011
3	Gastrin-Releasing PeptideIBA 10/2012 - 01/2006
3	Bombesin Receptors (Bombesin Receptor)IBA 10/2012 - 01/2006
3	Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA 10/2012 - 01/2006
3	Free RadicalsIBA 01/2010 - 10/2003
2	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 05/2013
2	Glutamate Receptors (Glutamate Receptor)IBA 01/2019 - 02/2010
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 06/2008
2	N-Methylaspartate (NMDA)IBA 01/2019 - 02/2010
2	3-nitrotyrosineIBA 12/2017 - 12/2014
2	Phosphopyruvate Hydratase (Enolase)IBA 07/2013 - 04/2011
2	Toll-Like Receptor 4IBA 10/2012 - 01/2012
2	CreatinineIBA 09/2012 - 09/2012
2	thiobarbituric acidIBA 03/2012 - 08/2003
2	EnzymesIBA 05/2011 - 04/2011
2	LipopolysaccharidesIBA 11/2009 - 02/2006
2	IronIBA 07/2009 - 02/2006
2	Xanthine OxidaseIBA 10/2008 - 08/2003
1	Neuroprotective AgentsIBA 12/2023
1	Minocycline (Cyclops)FDA LinkGeneric 12/2023
1	Prothrombin (Factor II)IBA 07/2023
1	AntithrombinsIBA 07/2023
1	C-Reactive ProteinIBA 07/2023
1	Factor XIII (Coagulation Factor XIII)IBA 07/2023
1	fibrin fragment D (D-dimer)IBA 07/2023
1	ChemokinesIBA 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2022
1	UteroglobinIBA 04/2021
1	LigandsIBA 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 01/2021
1	NeurograninIBA 12/2020
1	AmmoniaIBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2019
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2019
1	AntibodiesIBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Rosiglitazone (Avandia)FDA Link 01/2019
1	Rilmenidine (Hyperium)IBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2019
1	Sirolimus (Rapamycin)FDA Link 01/2019
1	Interleukin-1 (Interleukin 1)IBA 01/2019
1	Peroxidase (Myeloperoxidase)IBA 02/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2018
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2017

Therapy/Procedure

16	Ligation 01/2021 - 10/2003
7	Punctures 03/2020 - 02/2004
5	Critical Care (Surgical Intensive Care) 04/2023 - 01/2011
4	Length of Stay 12/2023 - 04/2012
3	Artificial Respiration (Mechanical Ventilation) 12/2023 - 04/2012
2	Therapeutics 03/2020 - 05/2011
1	Parenteral Nutrition 09/2022
1	Fecal Microbiota Transplantation 09/2022
1	Neonatal Intensive Care 09/2022
1	Activities of Daily Living (ADL) 01/2022